These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 8172423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME, Orth DN, Halmi NS, Zielinski AC, Davis DR, Chavez FT, Drucker WD.
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [Abstract] [Full Text] [Related]

  • 3. Differential secretion of pro-opiomelanocortin peptides by the pars distalis and pars intermedia of beagle dogs.
    Kemppainen RJ, Sartin JL.
    J Endocrinol; 1988 Apr; 117(1):91-6. PubMed ID: 2833553
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S, Crosby SR, Stewart MF, Jennings AM, McCall E, White A.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
    Willemse T, Mol JA.
    Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock.
    Matejec R, Kayser F, Schmal F, Uhle F, Bödeker RH, Maxeiner H, Kolbe JA.
    Peptides; 2013 Sep; 47():133-41. PubMed ID: 23891702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
    Gaspar L, Chan JS, Seidah NG, Chrétien M.
    Clin Invest Med; 1985 Sep; 8(2):167-75. PubMed ID: 3009068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for an ultradian secretion of adrenocorticotropin, beta-endorphin and alpha-melanocyte-stimulating hormone by the ovine anterior and intermediate pituitary.
    Engler D, Pham T, Fullerton MJ, Clarke IJ, Funder JW.
    Neuroendocrinology; 1989 Apr; 49(4):349-60. PubMed ID: 2541359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.